MP13-04 SPORADIC PRIMARY HYPERPARATHYROIDISM AND STONE DISEASE: A COMPREHENSIVE METABOLIC EVALUATION BEFORE AND AFTER PARATHYROIDECTOMY

Abstract

You have accessJournal of UrologyStone Disease: Epidemiology & Evaluation I1 Apr 2018MP13-04 SPORADIC PRIMARY HYPERPARATHYROIDISM AND STONE DISEASE: A COMPREHENSIVE METABOLIC EVALUATION BEFORE AND AFTER PARATHYROIDECTOMY Giovanni Marchini, Kauy Faria, Fabio Torricelli, Manoj Monga, Fabio Vicentini, Alexandre Danilovic, Miguel Srougi, William Nahas, and Eduardo Mazzucchi Giovanni MarchiniGiovanni Marchini More articles by this author , Kauy FariaKauy Faria More articles by this author , Fabio TorricelliFabio Torricelli More articles by this author , Manoj MongaManoj Monga More articles by this author , Fabio VicentiniFabio Vicentini More articles by this author , Alexandre DanilovicAlexandre Danilovic More articles by this author , Miguel SrougiMiguel Srougi More articles by this author , William NahasWilliam Nahas More articles by this author , and Eduardo MazzucchiEduardo Mazzucchi More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.476AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES to characterize the stone risk and the impact of parathyroidectomy on the metabolic profile of patients with primary hyperparathyroidism (PHPT) and urolithiasis. METHODS We analyzed the prospectively collected charts of patients treated at our stone clinic from Jan/2001-Jan/2016 searching for patients with PHPT and urolithiasis. Imaging evaluation of the kidneys, bones and parathyroid glands were assessed. We analyzed the demographic data, serum and urinary parameters before and after parathyroidectomy. Statistical analysis included paired T/Fisher/Spearman/ANOVA tests. Significance was set at p<0.05. RESULTS 51 patients were included. Mean age was 57.1±12.1years and 82.4% were female. Hypercalcemia was present in 84.3% of patients (Table 1). All eight patients with normal calcium had elevated PTH. Only two subjects did not have PTH above normal range, though both had elevated calcium. Before parathyroidectomy, mean calcium and PTH levels were 11.2±1.0mg/dL and 331±584pg/dL, respectively (Table 2). The most common urinary disorders were low urinary volume (64.7%), hypercalciuria (60.8%), high urinary pH (41.2%) and hypocitraturia (31.4%). After parathyroidectomy, the number of patients with hypercalcemia (n=4;7.8%), elevated PTH (n=17;33.3%) and hypophosphatemia (n=3;5.9%) significantly decreased (p<0.001). The number of urinary abnormalities decreased and there was a reduction in urinary calcium levels (p<0.001), pH (p=0.001) and citrate (p=0.003). A negative significant correlation was found between PTH and urinary calcium (R=-0.304; p=0.04). CONCLUSIONS Individuals with PHPT and nephrolithiasis frequently present elevated baseline PTH and calcium. Low volume, hypercalciuria, high urinary pH, and hypocitraturia are the most frequent urinary disorders. Parathyroidectomy is effective in normalizing serum calcium and PTH levels, though other urinary metabolic may persist. Patients should be monitored for the need for citrate supplementation. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e172 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Giovanni Marchini More articles by this author Kauy Faria More articles by this author Fabio Torricelli More articles by this author Manoj Monga More articles by this author Fabio Vicentini More articles by this author Alexandre Danilovic More articles by this author Miguel Srougi More articles by this author William Nahas More articles by this author Eduardo Mazzucchi More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...